Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19

Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19

Thrombosis is a known complication of SARS-CoV-2 infection, particularly within a severely symptomatic subset of patients with COVID-19 disease, in whom an aggressive host immune response leads to cytokine storm syndrome (CSS). The incidence of thrombotic events coinciding with CSS may contribute to...

Full description

Bibliographic Details
Main Authors: Faria Khimani, Adam J. Wolf, Braian Yoon, Amy Blancke, Coltin Gerhart, Dakota Endsley, Alleyna Dougherty, Anish K. Ray, Angelito F. Yango, Stuart D. Flynn, Gregory Y.H. Lip, Stevan A. Gonzalez, Mohanakrishnan Sathyamoorthy
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Thrombosis Update
Subjects:
COVID-19
Thrombosis
Coagulopathy
Anti-thrombotics in COVID-19
Anticoagulation in COVID-19
Deep vein thrombosis in COVID-19
Online Access:http://www.sciencedirect.com/science/article/pii/S266657272200030X

Internet

http://www.sciencedirect.com/science/article/pii/S266657272200030X

Similar Items